Medanta-The Medicity

Gurgaon, Haryana 122001

0 studies enrolling now · 10 studies all time

What they study most

Atypical Hemolytic Uremic Syndrome, COVID-19, Chronic Hepatitis B, Dyslipidemia, Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN), Pulmonary Arterial Hypertension, Rheumatoid Arthritis, Solid Tumors, Type2 Diabetes

Studies at this site

• A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS) — Running, not enrolling
• A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Pediatric Participants With Atypical Hemolytic Uremic Syndrome (aHUS) — Running, not enrolling
• Screening Study for Participants With Malignant Tumors — Completed
• Study to Evaluate the Antiviral Efficacy, Safety and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Pediatric Participants With Chronic Hepatitis B Infection — Running, not enrolling
• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• A Study of Atezolizumab (Anti-PD-L1 Antibody) as Adjuvant Therapy After Definitive Local Therapy in Patients With High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck — Stopped early
• A Study of Baricitinib (LY3009104) in Participants With COVID-19 — Completed
• An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension — Completed
• An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis — Completed
• Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy — Completed